CellRev developed a range of proprietary bioprocessing enzymes to increase yield, improve process consistency, and deliver better manufacturing outcomes. The IP was sold to C-LEcta in September 2025.
| Website | http://www.cellrev.co.uk |
| Employees | View employees |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Keywords | Manufacturing Efficiency, Bioprocessing Solutions, Biomanufacturing, Cell Manufacturing, Cell Culture, Cell Growth, Cell Technology, Biotechnology, Pharmaceutical Manufacturing, Upstream Processing, Cell Line Development, Process Optimization, Bioreactor Technology, Cell Expansion, Cell Therapy, Regenerative Medicine, Biopharma, Life Sciences, Process Engineering |
| Competitors | O2 (Telefónica UK), FR Tees Solutions Limited, EE, Three UK, Sky, giffgaff, Lebara, FilmFlex Movies, Plusnet, BT Group +32 more (view full list) |
Looking for a particular CellRev employee's phone or email?